United States

Pacific Meso Center adds Wong to research team

Monday, June 11, 2012 03:42 PM

The Pacific Meso Center (PMC), a division of the Pacific Heart, Lung & Blood Institute focused on research and treatment of malignant pleural mesothelioma (MPM), has appointed Dr. Raymond M. Wong, PhD, as its new scientific researcher.

More... »

Blaze Bioscience raises $5M in Series A financing

Monday, June 11, 2012 03:36 PM

Blaze Bioscience, a privately-held Seattle-based biotechnology company dedicated to developing products that assist surgeons in their quest to improve the lives of cancer patients, has raised $5 million in Series A financing.

More... »

Profil Institute, Florida Hospital to establish center for metabolic research

Monday, June 11, 2012 12:16 PM

Profil Institute for Clinical Research, a company focused on early phase clinical trials for diabetes and obesity, and Florida Hospital, one of nation's largest clinical care providers, formed a joint venture to establish a state-of-the-art early phase clinical services center for metabolic disease research, including diabetes, obesity and cardiometabolic diseases.

More... »

InnoPharma raises $8M in venture debt

Monday, June 11, 2012 12:04 PM

InnoPharma, a sterile product development company of Piscataway, N.J., has closed on an $8 million growth capital financing from Comerica Bank and NXT Capital Venture Finance.

More... »

Modulation Therapeutics receives $500,000 from MMRF for cancer treatment

Monday, June 11, 2012 11:54 AM

The Multiple Myeloma Research Foundation (MMRF) has awarded $500,000 through its Biotech Investment Award (BIA) program to Modulation Therapeutics, an early-stage pharmaceutical company which has licensed MTI-101 from the Moffitt Cancer Center.

More... »

Navidea Biopharmaceuticals opens new facility in Andover, Mass.

Monday, June 11, 2012 10:43 AM

Navidea Biopharmaceuticals, a Dublin, Ohio-based specialty biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, has opened its new business and commercialization facility in Andover, Mass.

More... »

Mount Sinai researchers develop multi-target approach to treating tumors

Friday, June 8, 2012 02:38 PM

Researchers from Mount Sinai School of Medicine developed a cancer model built in the fruit fly Drosophila, then used it to create a whole new approach to the discovery of cancer treatments: AD80.

More... »

PhaseBio raises additional $23M in Series B financing

Thursday, June 7, 2012 12:05 PM

PhaseBio Pharmaceuticals, a Malvern, Penn.-based, privately-held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, has raised a total of $48.4 million from its Series B financing following receipt of the third tranche to advance the company's product development programs.

More... »

Complete Genomics to restructure, cut 55 jobs

Wednesday, June 6, 2012 01:19 PM

Complete Genomics, a whole human genome sequencing company based in Mountain View, Calif., is taking steps to reduce cash consumption and has engaged Jefferies & Company to assist it in exploring strategic alternatives.

More... »

Abbott named as one of the 'Best Places to Work in Industry'

Tuesday, June 5, 2012 08:04 AM

Abbott Laboratories was once again named one of the "Best Places to Work in Industry" by The Scientist magazine, ranking No. 14 on the 2012 list. This is the ninth time that Abbott has been on the list since The Scientist first started ranking companies in 2003.

More... »